How much is Eclipsebio worth in 2026?

Eclipsebio has a current valuation of $39.9M based on their Later Stage VC round and secondary market data.

How much funding has Eclipsebio raised?

Eclipsebio has raised $23.9M in total funding across 0 funding rounds.

Eclipsebio

Website

Eclipsebio valuation and funding history | Last updated: November 20, 2025

Current Valuation

$39.9M

As of November 20, 2025

Total Funding Raised

$23.9M

Last Round

Later Stage VC

$4.9M

Last Funding

Nov 2025

Funding date

Capital Efficiency

1.67x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Eclipsebio is currently valued at $39.9M as of November 20, 2025. The company has raised a total of $23.9M in funding.

Capital Efficiency

With a capital efficiency ratio of 1.67x, Eclipsebio has achieved a valuation that is 1.67 times the total capital raised.

Track Eclipsebio Valuation Updates

Get notified when Eclipsebio raises new funding or valuation changes

Explore More Data

Detailed analysis for Eclipsebio

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Eclipsebio's valuation history, funding rounds, and growth metrics.

No credit card required

What is Eclipsebio Worth in 2026?

Eclipsebio is a leading private company in the technology sector. Track Eclipsebio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Eclipsebio Valuation is Determined

Private company valuations like Eclipsebio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.